the standard treatment is transurethral resection
the prognosis for inverted papilloma is pathetic, with a recurrence rate of approximately 65%
the likelihood of synchronous urothelial carcinoma is 26%
has been shown to harbor p53 gene mutations
A. the standard treatment is transurethral resection
infiltrative proximal penile urethral carcinomas
infiltrative distal penile urethral carcinomas
recurrent proximal penile urethral carcinoma after laser resection
T3/N2/M0 at bulbar urethra
only in females
associated with chronic irritation, polypoid cystitis, and cystitis glandularis
no risk for squamous cell carcinoma
treated with estrogen, if symptomatic
working with organic chemicals and dyes
abuse of pain-control medications especially phenacetin
exposure to arsenic and aromatic amines
schistosomiasis
ascending urethrography
voiding cystourethrography
MRI
IVU
10%
20%
30%
40%
single intravesical chemotherapy
TURBT
intravesical BCG vaccine
multiple bladder biopsies
RB
cyclin A
HRAS
CD-44
mid prostate to the verumontanum at the 5 and 7 oclock positions
lateral margins of the prostate at the 10 and 2 oclock positions
entire area distal to the urethral crest
area between ejaculatory duct openings and prostatic utricle
urine cytology
CT urography
cystoscopy
renal function tests
30%
40%
50%
60%
often of high-grade sarcomas
often associated with muscularis propria invasion
due to vesical polyps occluding ureteric orifices
should be resected but not diathermized
continue the procedure as perforations at this site do no harm
abort the procedure and leave a urethral catheter
convert tumor removal to open method and repair the defect
perform abdominal exploration and manage accordingly
frequently found in association with high-grade or extensive TCC
has a rate of progression to muscle invasion of 10-25%
significant areas of CIS are easily missed by routine cystoscopy
treatment begins with TURBT
epirubicin
mitomycin c
BCG
none of the above
tumor stage
tumor grade
lymphovascular invasion
lymph node spread
obstructive LUTS are common presentations and occur in association with carcinoma in situ
might present as perineal abscesses and fistulae
could be asymptomatic
venereal diseases increase the risk of urethral cancers
0.6 - 2%
2 - 6%
6 - 10%
12 - 16%
adenocarcinoma
transitional cell carcinoma
squamous cell carcinoma
basal cell carcinoma
irritative bladder symptoms
obstructive bladder symptoms
palpable suprapubic mass on physical examination
painless profuse hematuria
well-differentiated tumor with broad-based invasive font
marked atypia distributed on wide areas of superficial urothelium
atypia is present
no atypia but marked degenerative epithelial changes
the lesion is solitary and no associated CIS
physically, a surgical margin of 2-cm can be obtained
the resected area should be far enough from ureteral orifices and the bladder neck
all of the following
obesity
consuming artificial sweeteners
asbestosis
analgesic abuse
adenocarcinoma
transitional cell carcinoma
squamous cell carcinoma
comparable
en bloc resection involving total penectomy, cystoprostatectomy, resection of the pubic rami and urogenital diaphragm, with pelvic lymphadenectomy. In addition, creating a urinary diversion.
total penectomy involving removal of the penis, urethra, and penile root
partial penectomy involving excision of the malignant lesion with 2-cm margins
transurethral resection or fulguration
transitional cell carcinoma
squamous cell carcinoma
adenocarcinoma
small cell carcinoma
history of pulmonary TB
total incontinence
immunosuppression
impaired renal function
2 - 4%
4 - 6%
6 - 8%
8 - 10%
nodular or sessile lesions usually invade muscle
papillary bladder tumors are typical of low stage and grade
carcinoma in situ appears as a flat, velvety patch
sarcomas commonly invade bladder base and ureteral orifices causing obstructions
cisplatin
BCG
mitomycin C
5-fluorouracil
leiomyosarcoma
rhabdosarcoma
carcinosarcoma
neurosarcoma